[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Neurodiagnostic and Monitoring Devices Market Size, Trends, Analysis, and Outlook By Product (Magnetoencephalography (MEG), Electromyography (EMG), Transcranial Cerebral Oximeters, Electroencephalogram (EEG), Cerebral Oximeters, Intracranial Pressure Monitor), By End-User (Operation Theatres, Hospitals, Clinics, Neurophysiological Laboratories), by Region, Country, Segment, and Companies, 2024-2030

March 2024 | 190 pages | ID: NCF9C82C0DD0EN
VPAResearch

US$ 3,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Neurodiagnostic and Monitoring Devices market size is poised to register 7.41% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Neurodiagnostic and Monitoring Devices market By Product (Magnetoencephalography (MEG), Electromyography (EMG), Transcranial Cerebral Oximeters, Electroencephalogram (EEG), Cerebral Oximeters, Intracranial Pressure Monitor), By End-User (Operation Theatres, Hospitals, Clinics, Neurophysiological Laboratories).

The future of neurodiagnostic and monitoring devices is driven by advancements in neurophysiology, medical imaging, and digital health technology aimed at enhancing diagnostic accuracy, prognostic assessment, and therapeutic monitoring in patients with neurological disorders such as epilepsy, stroke, and traumatic brain injury. Key trends include the development of portable, wireless EEG systems, ambulatory EEG recorders, and wearable neuroimaging devices that enable continuous, non-invasive monitoring of brain activity, seizure detection, and functional mapping in ambulatory and home settings. Additionally, there is a growing emphasis on the integration of artificial intelligence, machine learning algorithms, and cloud-based analytics into neurodiagnostic platforms to automate data interpretation, enhance diagnostic yield, and facilitate real-time decision-making by clinicians and caregivers. Moreover, advancements in multimodal neuroimaging techniques, high-density electrode arrays, and virtual reality-assisted rehabilitation tools enable comprehensive assessment of brain function, connectivity, and plasticity, driving continuous improvement and adoption of neurodiagnostic and monitoring devices in neurology clinics, neurocritical care units, and research laboratories..

Neurodiagnostic and Monitoring Devices Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Neurodiagnostic and Monitoring Devices market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Neurodiagnostic and Monitoring Devices survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Neurodiagnostic and Monitoring Devices industry.

Key market trends defining the global Neurodiagnostic and Monitoring Devices demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Neurodiagnostic and Monitoring Devices Market Segmentation- Industry Share, Market Size, and Outlook to 2030

The Neurodiagnostic and Monitoring Devices industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Neurodiagnostic and Monitoring Devices companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Neurodiagnostic and Monitoring Devices industry

Leading Neurodiagnostic and Monitoring Devices companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Neurodiagnostic and Monitoring Devices companies.

Neurodiagnostic and Monitoring Devices Market Study- Strategic Analysis Review

The Neurodiagnostic and Monitoring Devices market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
  • Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
  • Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
  • Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
  • Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
Neurodiagnostic and Monitoring Devices Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Neurodiagnostic and Monitoring Devices industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.

Neurodiagnostic and Monitoring Devices Country Analysis and Revenue Outlook to 2030

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.

North America Neurodiagnostic and Monitoring Devices Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Neurodiagnostic and Monitoring Devices market segments. Similarly, Strong end-user demand is encouraging Canadian Neurodiagnostic and Monitoring Devices companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Neurodiagnostic and Monitoring Devices market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Neurodiagnostic and Monitoring Devices Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Neurodiagnostic and Monitoring Devices industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Neurodiagnostic and Monitoring Devices market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Neurodiagnostic and Monitoring Devices Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Neurodiagnostic and Monitoring Devices in Asia Pacific. In particular, China, India, and South East Asian Neurodiagnostic and Monitoring Devices markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.

Latin America Neurodiagnostic and Monitoring Devices Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Neurodiagnostic and Monitoring Devices Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Neurodiagnostic and Monitoring Devices market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Neurodiagnostic and Monitoring Devices.

Neurodiagnostic and Monitoring Devices Market Company Profiles

The global Neurodiagnostic and Monitoring Devices market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Ambu AS, Bio Signal Group Corp, Cadwell Industries Inc, Compumedics Ltd, Delsys Inc, ELMIKO BIOSIGNALS sp. z o.o., General Electric Co., Jordan NeuroScience, Koninklijke Philips N.V., Lifelines Neuro Company LLC, Masimo Corp, Medtronic Plc, Motion Lab Systems Inc, Natus Medical Inc, neurocare group AG, Nihon Kohden Corp, NovaSignal Corp, RAUMEDIC AG, Viasonix Ltd.

Recent Neurodiagnostic and Monitoring Devices Market Developments

The global Neurodiagnostic and Monitoring Devices market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Neurodiagnostic and Monitoring Devices Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • SWOT Profile
  • Market Dynamics- Trends, Drivers, Challenges
  • Porter’s Five Forces Analysis
  • Macroeconomic Impact Analysis
  • Case Scenarios- Low, Base, High
Market Segmentation:

By Type

Stationary 3D and 4D Ultrasound Devices

Portable 3D and 4D Ultrasound Devices

By Display

Color Ultrasound

B/W Ultrasound

By Portability

Trolley or Cart-Based Ultrasound Systems

Compact/Handheld Ultrasound Systems

Point-of-Pare (PoC) Ultrasound Systems

By Application

Radiology or General Imaging

Obstetrics or Gynecology

Cardiology

Urology

Vascular

Orthopedic and Musculoskeletal

Pain Management

Others

By End-User

Hospitals

Surgical Centers and Diagnostic Centers

Maternity Centers

Ambulatory Care Centers

Research and Academia

Others

Geographical Segmentation:
  • North America (3 markets)
  • Europe (6 markets)
  • Asia Pacific (6 markets)
  • Latin America (3 markets)
  • Middle East Africa (5 markets)
Companies

Ambu AS

Bio Signal Group Corp

Cadwell Industries Inc

Compumedics Ltd

Delsys Inc

ELMIKO BIOSIGNALS sp. z o.o.

General Electric Co.

Jordan NeuroScience

Koninklijke Philips N.V.

Lifelines Neuro Company LLC

Masimo Corp

Medtronic Plc

Motion Lab Systems Inc

Natus Medical Inc

neurocare group AG

Nihon Kohden Corp

NovaSignal Corp

RAUMEDIC AG

Viasonix Ltd

Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY

1.1 Neurodiagnostic and Monitoring Devices Market Overview and Key Findings, 2024
1.2 Neurodiagnostic and Monitoring Devices Market Size and Growth Outlook, 2021- 2030
1.3 Neurodiagnostic and Monitoring Devices Market Growth Opportunities to 2030
1.4 Key Neurodiagnostic and Monitoring Devices Market Trends and Challenges
  1.4.1 Neurodiagnostic and Monitoring Devices Market Drivers and Trends
  1.4.2 Neurodiagnostic and Monitoring Devices Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Neurodiagnostic and Monitoring Devices Companies

2. NEURODIAGNOSTIC AND MONITORING DEVICES MARKET SIZE OUTLOOK TO 2030

2.1 Neurodiagnostic and Monitoring Devices Market Size Outlook, USD Million, 2021- 2030
2.2 Neurodiagnostic and Monitoring Devices Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024

3. NEURODIAGNOSTIC AND MONITORING DEVICES MARKET- STRATEGIC ANALYSIS REVIEW

3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis

4. NEURODIAGNOSTIC AND MONITORING DEVICES MARKET SEGMENTATION ANALYSIS AND OUTLOOK

4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Stationary 3D and 4D Ultrasound Devices
Portable 3D and 4D Ultrasound Devices
By Display
Color Ultrasound
B/W Ultrasound
By Portability
Trolley or Cart-Based Ultrasound Systems
Compact/Handheld Ultrasound Systems
Point-of-Pare (PoC) Ultrasound Systems
By Application
Radiology or General Imaging
Obstetrics or Gynecology
Cardiology
Urology
Vascular
Orthopedic and Musculoskeletal
Pain Management
Others
By End-User
Hospitals
Surgical Centers and Diagnostic Centers
Maternity Centers
Ambulatory Care Centers
Research and Academia
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030

5. REGION-WISE MARKET OUTLOOK TO 2030

5.1 Key Findings for Asia Pacific Neurodiagnostic and Monitoring Devices Market, 2025
5.2 Asia Pacific Neurodiagnostic and Monitoring Devices Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Neurodiagnostic and Monitoring Devices Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Neurodiagnostic and Monitoring Devices Market, 2025
5.5 Europe Neurodiagnostic and Monitoring Devices Market Size Outlook by Type, 2021- 2030
5.6 Europe Neurodiagnostic and Monitoring Devices Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Neurodiagnostic and Monitoring Devices Market, 2025
5.8 North America Neurodiagnostic and Monitoring Devices Market Size Outlook by Type, 2021- 2030
5.9 North America Neurodiagnostic and Monitoring Devices Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Neurodiagnostic and Monitoring Devices Market, 2025
5.11 South America Pacific Neurodiagnostic and Monitoring Devices Market Size Outlook by Type, 2021- 2030
5.12 South America Neurodiagnostic and Monitoring Devices Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Neurodiagnostic and Monitoring Devices Market, 2025
5.14 Middle East Africa Neurodiagnostic and Monitoring Devices Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Neurodiagnostic and Monitoring Devices Market Size Outlook by Application, 2021- 2030

6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030

6.1 US Neurodiagnostic and Monitoring Devices Market Size Outlook and Revenue Growth Forecasts
6.2 US Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Neurodiagnostic and Monitoring Devices Industry Drivers and Opportunities

7. NEURODIAGNOSTIC AND MONITORING DEVICES MARKET OUTLOOK ACROSS SCENARIOS

7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case

8. NEURODIAGNOSTIC AND MONITORING DEVICES COMPANY PROFILES

8.1 Profiles of Leading Neurodiagnostic and Monitoring Devices Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Ambu AS
Bio Signal Group Corp
Cadwell Industries Inc
Compumedics Ltd
Delsys Inc
ELMIKO BIOSIGNALS sp. z o.o.
General Electric Co.
Jordan NeuroScience
Koninklijke Philips N.V.
Lifelines Neuro Company LLC
Masimo Corp
Medtronic Plc
Motion Lab Systems Inc
Natus Medical Inc
neurocare group AG
Nihon Kohden Corp
NovaSignal Corp
RAUMEDIC AG
Viasonix Ltd

9. APPENDIX

9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information


More Publications